A

AtriCure, Inc. Tech Stack

Medical devices for atrial fibrillation treatment and surgical pain management

Medical Equipment Manufacturing Mason, Ohio 1,001–5,000 employees Founded 2000 Public Company

AtriCure manufactures surgical ablation and nerve-block devices for electrophysiologists and cardiothoracic surgeons. The tech stack reveals a manufacturing-centric operation: Six Sigma, FMEA, CAD, and quality-control tools dominate, with Microsoft enterprise suite for operations—no cloud data platforms or ML tooling. Hiring is sales-heavy (63 roles) relative to engineering (17), and pain points cluster around institutional adoption and manufacturing efficiency, signaling a commercial-expansion phase rather than product-technology pivot.

Tech Stack 22 technologies

Core StackActive Directory Intune Dynamics 365 Six Sigma FMEA PowerPoint Outlook Excel Word Windows Azure Azure Entra ID Microsoft 365 Microsoft Office Dynamics GP CAD DocuWare Webex BlackLine Google Analytics 4 Looker Studio Google Tag Manager

What AtriCure, Inc. Is Building

◆Challenges

Driving institutional therapy adoption
Increasing adoption of cryo nerve block therapy
Audit readiness
Increasing adoption of pain management therapy
Improving manufacturing process efficiency
Continuous improvement of quality
Introducing new cardiac procedures
Quality control
Reducing defect rates
Improving patient recovery and satisfaction

▲Active Projects

Drive institutional therapy adoption of cryo nerve block procedure
Strategic sales plan for designated territory
Training surgical and or staff on pain management devices
Fixture design in cad prototypes
Clinical process improvement projects
Guidance and support for physicians during live surgical procedures
New product launch planning
Process analytics for preemptive defect control
Therapy development
New manufacturing processes and equipment

Hiring Activity

Accelerating180 roles · 80 in 30d

Department

Sales

63

Healthcare

28

Engineering

17

Manufacturing

14

Marketing

7

Product

7

Research

6

HR

5

Seniority

Mid

44

Manager

42

Principal

29

Junior

17

Senior

15

Director

10

Intern

5

Staff

4

Notable leadership hires: Area Director

Company intelligence

Find more companies like AtriCure, Inc. by tech stack, pain points and active projects

Get started free

About AtriCure, Inc.

AtriCure is a publicly traded medical-device manufacturer headquartered in Mason, Ohio, focused on two primary markets: atrial fibrillation (Afib) treatment and post-operative pain management. The Afib portfolio includes the Isolator Synergy Ablation System (FDA-approved for persistent Afib), the AtriClip Left Atrial Appendage Exclusion System (described as the most widely sold LAA management device globally), and Hybrid AF Therapy (a minimally invasive approach for long-standing persistent Afib). For pain management, the company offers cryo nerve-block probes (cryoICE cryoSPHERE+ and cryoSPHERE MAX) used in cardiac and thoracic procedures. The customer base spans electrophysiologists, cardiothoracic surgeons, and thoracic surgeons globally. Operations span eight countries, with active hiring across North America, Western Europe, and Asia-Pacific.

HeadquartersMason, Ohio

Company Size1,001–5,000 employees

Founded2000

Hiring MarketsUnited States, Netherlands, Japan, United Kingdom, Germany, Australia, Singapore, China

Frequently Asked Questions

What is AtriCure's primary focus?

AtriCure develops and manufactures medical devices for atrial fibrillation treatment and surgical pain management. Key products include the Isolator Synergy Ablation System, AtriClip Left Atrial Appendage Exclusion System, and cryo nerve-block probes for procedural pain relief.

What tech stack does AtriCure use?

AtriCure's stack is manufacturing and operations-focused: Six Sigma, FMEA, CAD, DocuWare, Microsoft 365 (Dynamics GP, Dynamics 365, Office), Azure, and Google Analytics. No cloud data or ML platforms are in active use.